Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
Clinical trial NCT00048386 · COMPLETED
Trial details
- NCT number
- NCT00048386
- Sponsor
- Malcolm Brenner
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Primary completion
- 2004-12-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.